Terns Pharmaceuticals, Inc.

Q1 2024 13F Holders

Symbol
TERN
CUSIP
880881107
Type
Equity
Class
COM
Num filers
113
Total reported value, excl. options
$415M
Manager Report Date Value ($000) Shares Option Type